thirty-four infants and children ranging in age from 2.5 to 180 months ( mean , 40 months ) were treated with parenteral moxalactam ( 150 mg/kg per day ) for suspected or proved bacterial infections outside the central nervous system .
C0021270
infants
C0008059
children